Keywords: پادبَند یا ضد انعقاد; AF; atrial fibrillation; LA; left atrium; LAA; left atrial appendage; LSPV; left superior pulmonary vein; PV; pulmonary vein; TEE; transesophageal echocardiogram/echocardiography; TTE; transthoracic echocardiogram; Atrial fibrillation; Catheter ablation;
مقالات ISI پادبَند یا ضد انعقاد (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پادبَند یا ضد انعقاد; Anticoagulation; Deep vein thrombosis; Nonvitamin K antagonist oral anticoagulant; Venous thromboembolism; Pulmonary embolism
Keywords: پادبَند یا ضد انعقاد; Venous thromboembolism; Deep vein thrombosis; Pulmonary embolism; Anticoagulation; Thrombolysis; Inferior vena cava filter;
Keywords: پادبَند یا ضد انعقاد; Chronic liver disease; Cirrhosis; Hemostasis; Thrombosis; Anticoagulation
Keywords: پادبَند یا ضد انعقاد; Disease management; frail elders; heart failure; pneumonia; mild cognitive impairment; meaningful activities in the nursing home; anticoagulation; atrial fibrillation; multiple chronic conditions; clinical guidelines;
Keywords: پادبَند یا ضد انعقاد; esophagectomy; atrial fibrillation; mitral stenosis; anticoagulation; stroke; mortality; guidelines;
Keywords: پادبَند یا ضد انعقاد; Anticoagulation; Antiplatelet; Intracranial hemorrhage; Coagulopathy
Keywords: پادبَند یا ضد انعقاد; Atrial fibrillation; Stroke; Thromboembolism; Anticoagulation; Barriers; Warfarin; New oral anticoagulants
Keywords: پادبَند یا ضد انعقاد; Anticoagulation; Atrial fibrillation; Elderly; Bleeding; Warfarin; Antiplatelet agents; Risk stratification;
Keywords: پادبَند یا ضد انعقاد; anticoagulation; apixaban; atrial fibrillation; cost-effectiveness; dabigatran; rivaroxaban;
Keywords: پادبَند یا ضد انعقاد; Intracerebral hemorrhage; Anticoagulation; Antiplatelet therapy; Atrial fibrillation; Prosthetic heart valve; Venous thromboembolism;
Keywords: پادبَند یا ضد انعقاد; anticoagulation; atrial fibrillation; stroke; ACS; acute coronary syndrome(s); AF; atrial fibrillation; DOAC; direct-acting oral anticoagulant; DAPT; dual antiplatelet therapy; FFP; fresh frozen plasma; ICH; intracranial hemorrhage; INR; international n
Keywords: پادبَند یا ضد انعقاد; Anticoagulation; Novel oral anticoagulants; Atrial fibrillation; Factor IIa inhibitors; Factor Xa inhibitors; Stroke;
Keywords: پادبَند یا ضد انعقاد; Neonatal thrombosis; Anticoagulation; Prothrombotic disorder; Thrombolysis; Perinatal arterial ischemic stroke; Cerebral sinovenous thrombosis;
Keywords: پادبَند یا ضد انعقاد; Thrombosis; Cirrhosis; Portal vein; Anticoagulation; Thrombophilia; Thromboelastography; Malignancy;
Keywords: پادبَند یا ضد انعقاد; AF; atrial fibrillation; BMI; body mass index; CI; confidence interval; HDL-C; high-density lipoprotein cholesterol; HR; hazard ratio; INR; international normalized ratio; LDL-C; low-density lipoprotein cholesterol; NOAC; non-vitamin K antagonist oral a
Keywords: پادبَند یا ضد انعقاد; Postoperative atrial fibrillation; Anticoagulation; Warfarin; Novel oral anticoagulants;
Keywords: پادبَند یا ضد انعقاد; anticoagulation; cardiomyopathy; children;
Keywords: پادبَند یا ضد انعقاد; Venous thromboembolism; Ulcerative colitis; Colectomy; Thrombus; Anticoagulation
Keywords: پادبَند یا ضد انعقاد; VTE; venous thromboembolism; PE; pulmonary embolism; MEDENOX trial; “prophylaxis in medical patients with enoxaparin” trial; AHRQ PSI 12; Agency for Healthcare Research and Quality Patient Safety Indicators 12, version 4.2; OR; odds ratio; DVT; deep v
Keywords: پادبَند یا ضد انعقاد; Anticoagulation; Thrombin; Sulfation; Factor XIa;
Keywords: پادبَند یا ضد انعقاد; total knee arthroplasty; anticoagulation; warfarin; bridging; heparin; complications;
Keywords: پادبَند یا ضد انعقاد; Thrombolysis; anticoagulation; stroke; dabigatran; thrombin time; partial thromboplastin time;
Keywords: پادبَند یا ضد انعقاد; anticoagulation; d-dimer; compression therapy; factor Xa inhibition
Keywords: پادبَند یا ضد انعقاد; Vascular anomalies; Anticoagulation; Surgical drains; Wound care; Compression garment
Keywords: پادبَند یا ضد انعقاد; Atrial fibrillation; Anticoagulation; Pacemaker; Defibrillator; Surgery;
Keywords: پادبَند یا ضد انعقاد; Otomastoiditis; Lateral sinus thrombosis; Anticoagulation; Acute otitis media; Intracranial; Complications
Keywords: پادبَند یا ضد انعقاد; Lateral sinus thrombosis; Acute otitis media; Intracranial pressure; Papilledema; Mastoidectomy; Anticoagulation; Sigmoid sinus thrombosis
Keywords: پادبَند یا ضد انعقاد; Inferior vena cava filter; Cancer; Anticoagulation; Bleeding
Keywords: پادبَند یا ضد انعقاد; Anticoagulation; atrial fibrillation; stroke mechanism; prognosis
Keywords: پادبَند یا ضد انعقاد; Atrial fibrillation; chronic obstructive pulmonary disease (COPD); anticoagulation; outcomes;
Keywords: پادبَند یا ضد انعقاد; Anticoagulation; computed tomography pulmonary angiogram (CTPA); embolectomy; IVC filter; massive pulmonary embolism; pulmonary embolism; submassive pulmonary embolism; thrombolysis; venous thrombo-embolism
Keywords: پادبَند یا ضد انعقاد; Atrial fibrillation ablation; Anticoagulation; Intracardiac echocardiography; Reversal agents; Novel oral anticoagulants; Warfarin;
Keywords: پادبَند یا ضد انعقاد; Atrial fibrillation; Anticoagulation; Prevalence; Coumarins; Warfarin; Vitamin K antagonistsFibrilhação auricular; Anticoagulação; Prevalência; Coumarinicos; Varfarina; Antagonistas da vitamina K
Keywords: پادبَند یا ضد انعقاد; Venous thromboembolism; Deep venous thrombosis; Pulmonary embolism; Anticoagulation; Thrombophilia
Keywords: پادبَند یا ضد انعقاد; Warfarin; ASA; intracranial hemorrhage; anticoagulation;
Keywords: پادبَند یا ضد انعقاد; Anticardiolipin antibodies; anticoagulation; antiphospholipid syndrome; complement; β2-glycoprotein-I antibodies; lupus anticoagulant; obstetric morbidity; thrombosis
Keywords: پادبَند یا ضد انعقاد; Anticoagulation; Antithrombotic; Atrial fibrillation; Stroke;
Keywords: پادبَند یا ضد انعقاد; Pulmonary embolism; Diagnosis; Elderly; Clinical probability; Anticoagulation; Management
Keywords: پادبَند یا ضد انعقاد; extracorporeal circulation; anticoagulation; coagulation; thromboelastography; surgical blood loss; cardiopulmonary bypass; heparin; protamine;
Keywords: پادبَند یا ضد انعقاد; Anticoagulation; atrial fibrillation; warfarin; stroke management; transient ischemic attack;
Keywords: پادبَند یا ضد انعقاد; Venous thromboembolism; Extended treatment; Anticoagulation; Rivaroxaban; Cost-effectiveness analysis; Markov model;
Keywords: پادبَند یا ضد انعقاد; Venous thromboembolism; Deep venous thrombosis; Anticoagulation
Keywords: پادبَند یا ضد انعقاد; Acute coronary syndrome; Anticoagulation; Antithrombotic therapy; Aspirin; Atrial fibrillation; Clopidogrel; Coronary intervention; Coronary stent; Drug-eluting stent; Platelet inhibitor; Stent; Triple therapy; Warfarin
Keywords: پادبَند یا ضد انعقاد; Antiplatelet; Anticoagulation; Bleeding; Thrombosis; Novel oral anticoagulants
Keywords: پادبَند یا ضد انعقاد; Anticoagulation; Heparin-induced thrombocytopenia; High-risk recipient; Liver transplantation;
Keywords: پادبَند یا ضد انعقاد; labor; intrapartum; cardiac disease; pregnancy; heart; pregnancy physiology; endocarditis prophylaxis; anticoagulation; fluid management; oxygen supplementation; hemodynamic monitoring; analgesia; pacemakers/AICD; operative delivery; cesarean delivery; po
Keywords: پادبَند یا ضد انعقاد; head injury; anticoagulation; medical imaging; prognosis
Keywords: پادبَند یا ضد انعقاد; Acute ischemic stroke; anticoagulation; neurologic degeneration; venous thromboembolism; outcomes;
Keywords: پادبَند یا ضد انعقاد; Thrombophilias; Neuraxial anesthesia; Thrombocytopenia; Anticoagulation; Epidural/Spinal hematoma; Hemophilia; Bleeding disorders